Lianyungang Runzhong Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is AMIFOSTINE, with a corresponding US DMF Number 21765.
Remarkably, this DMF maintains an Active status since its submission on June 26, 2008, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of May 24, 2014, and payment made on January 23, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II